Laboratory findings in hypertensive disorders of pregnancy

Journal of the National Medical Association

Volumn 88, Issue 12, 1996, Pages 794-798

  FitzGerald, Mary Pat ^a   Floro, Claro ^a   Siegel, Jamie ^a   Hernandez, Enrique ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Hypertension; Platelet count; Pregnancy

Indexed keywords

BILIRUBIN; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D; FIBRINOGEN;

ADOLESCENT; ADULT; ARTICLE; BLEEDING; BLOOD; BLOOD CELL COUNT; BLOOD CLOTTING DISORDER; DELIVERY; ENZYMOLOGY; FEMALE; FORECASTING; HUMAN; HYPERTENSION; LIVER; OBSTETRIC ANESTHESIA; PARTIAL THROMBOPLASTIN TIME; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PROTHROMBIN TIME; REGIONAL ANESTHESIA; RETROSPECTIVE STUDY; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; ANESTHESIA, CONDUCTION; ANESTHESIA, OBSTETRICAL; BILIRUBIN; BLOOD CELL COUNT; BLOOD COAGULATION DISORDERS; DELIVERY, OBSTETRIC; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; FORECASTING; HEMORRHAGE; HUMANS; HYPERTENSION; LIVER; PARTIAL THROMBOPLASTIN TIME; PLATELET COUNT; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PROTHROMBIN TIME; RETROSPECTIVE STUDIES;

EID: 0030329453     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Gibson G, Hunter D, Neame PB, Kelton JG. Thrombocytopenia in pre-eclampsia and eclampsia. Semin Thromb Hemost. 1982;8:234-247.
2. Pritchard JA, Cunningham FG, Mason RA. Coagulation changes in eclampsia: their frequency and pathogenesis. Am J Obstet Gynecol. 1976;8:855-864.
3. Romera R, Mazor M, Lockwood CJ, Emamian M, Belanger KP, Hobbins JC, et al. Clinical significance, prevalence and natural history of thrombocytopenia in pregnancy-induced hypertension. Am J Perinatol. 1989;1:32-38.
4. Burrows RF, Hunter DJS, Andrew M, Kelton JG. A prospective study investigating the mechanism of thrombocytopenia in preeclampsia. Obstet Gynecol. 1987;70:334-338.
5. Saleh AA, Bottoms SF, Welch RA, Ali AM, Mariona FG, Mammen EF. Preeclampsia, delivery and the hemostatic system. Am J Obstet Gynecol. 1987;157:331-336.
6. Davidson EC, Phillips LL. Coagulation studies in the hypertensive toxemias of pregnancy. Am J Obstet Gynecol. 1972;113:905-911.
7. Aarnoudse JG, Houthoff HJ, Weits J, Vellenga E, Huisjes HJ. A syndrome of liver damage and intravascular coagulation in the last trimester of normotensive pregnancy: a clinical and histopathological study. Br J Obstet Gynaecol. 1986;93:145-155.
8. Kobayashi T, Terao T. Preeclampsia as chronic disseminated intravascular coagulation. Study of two parameters: thrombin-antithrombin III complex and D-dimers. Gynecol Obstet Invest. 1987;24:170-178.
9. McKay DG. Hematologic evidence of disseminated intravascular coagulation in eclampsia. Obstet Gynecol Surv. 1972;27:399-417.
10. Van Dam PA, Renier M, Baekelandt M, Buytaert P, Uyttenbroeck F. Disseminated intravascular coagulation and the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia. Obstet Gynecol. 1989;73:97-102.
11. Weiner CP. The obstetric patient and disseminated intravascular coagulation. Clin Perinatol. 1986;4:705-717.
12. Lopez-Llera M, De La Luz Espinosa M, Diaz de Leon M, Linares GR. Abnormal coagulation and fibrinolysis in eclampsia: a clinical and laboratory correlation study. Am J Obstet Gynecol. 1976;7:681-687.
13. Thiagarajah S, Bourgeois FJ, Harbert GM Jr, Caudle MR. Thrombocytopenia in preeclampsia: associated abnormalities and management principles. Am J Obstet Gynecol. 1984;150:1-7.
14. Sibai BM, Taslimi MM, el-Nazer A, Amon E, Mabie BC, Ryan GM. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol. 1986;155:501-509.
15. de Boer K, ten Cate JW, Sturk A, Borm JJ, Treffers PE. Enhanced thrombin generation in normal and hypertensive pregnancy. Am J Obstet Gynecol. 1989;160:95-100.
16. Hayakawa M, Maki M. Coagulation-fibrinolytic and kinin-forming systems in toxemia of pregnancy. Gynecol Obstet Invest. 1988;26:190-191.
17. Henderson AH, Pugsley DJ, Thomas DP. Fibrin degradation products in preeclamptic toxaemia and eclampsia. Br Med J. 1970;3:545-547.
18. Bonnar J, McNicol GP, Douglas AS. Coagulation and fibrinolytic systems in pre-eclampsia and eclampsia. Br Med J. 1971;2:12-16.
19. Gordon YB, Ratky SM, Baker LR, Letchworth AT, Leighton PC, Chard T. Circulating levels of fibrin fibrinogen degradation fragment E measured by radioimmunoassay in pre-eclampsia. Br J Obstet Gynaecol. 1976;83:287-291.
20. Leduc L, Wheeler JM, Kirshon B, Mitchell P, Cotton DB. Coagulation profile in severe preeclampsia. Obstet Gynecol. 1992;79:14-18.
21. The American College of Obstetricians and Gynecologists. Management of Pre-Eclampsia. Washington, DC: The American College of Obstetricians and Gynecologists; 1986. ACOG Technical Bulletin Number 91.
22. Schwartz SI. Hemostasis, surgical bleeding, and transfusion. In: Schwartz SI, Shires GT, Spencer FL, eds. Principles of Surgery. 6th ed. New York, NY: McGraw-Hill; 1994:95-118.